Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-01-17 Sale |
2024-01-19 5:19 pm |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
9,781 | $17.23 | $168,527 | 194,605 (Direct) |
View |
2024-01-17 Sale |
2024-01-19 5:19 pm |
PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer |
9,786 | $17.23 | $168,613 | 216,860 (Indirect Direct) |
View |
2024-01-17 Sale |
2024-01-19 5:19 pm |
PLIANT THERAPEUTICS INC. | PLRX | Coulie Bernard President and CEO |
25,721 | $17.23 | $443,173 | 725,699 (Indirect Direct) |
View |
2024-01-17 Sale |
2024-01-19 5:18 pm |
PLIANT THERAPEUTICS INC. | PLRX | Lefebvre Eric Chief Medical Officer |
10,295 | $17.23 | $177,383 | 156,920 (Direct) |
View |
2024-01-17 Sale |
2024-01-19 5:11 pm |
PLIANT THERAPEUTICS INC. | PLRX | Ouimette Mike General Counsel & Corp. Sec'y |
5,197 | $17.23 | $89,544 | 55,246 (Direct) |
View |
2023-08-03 Sale |
2023-08-07 8:50 pm |
PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer |
34,919 | $20.01 | $698,581 | 298,171 (Indirect Direct) |
View |
2023-07-20 Sale |
2023-07-21 4:40 pm |
PLIANT THERAPEUTICS INC. | PLRX | Ouimette Mike General Counsel & Corp. Sec'y |
4,755 | $17.55 | $83,450 | 60,443 (Direct) |
View |
2023-07-17 Sale |
2023-07-19 8:31 pm |
PLIANT THERAPEUTICS INC. | PLRX | Ouimette Mike General Counsel & Corp. Sec'y |
12,778 | $18.01 | $230,120 | 65,198 (Direct) |
View |
2023-07-17 Sale |
2023-07-19 8:29 pm |
PLIANT THERAPEUTICS INC. | PLRX | Lefebvre Eric Chief Medical Officer |
22,321 | $18.01 | $401,981 | 167,215 (Direct) |
View |
2023-07-17 Sale |
2023-07-19 8:26 pm |
PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer |
17,937 | $18.01 | $323,029 | 250,974 (Indirect Direct) |
View |
2023-07-17 Sale |
2023-07-19 8:23 pm |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
19,771 | $18.01 | $356,058 | 203,999 (Direct) |
View |
2023-07-17 Sale |
2023-07-19 8:20 pm |
PLIANT THERAPEUTICS INC. | PLRX | Coulie Bernard President and CEO |
70,150 | $18.01 | $1,263,338 | 751,420 (Indirect Direct) |
View |
2023-03-30 Sale |
2023-04-03 7:07 pm |
PLIANT THERAPEUTICS INC. | PLRX | Ouimette Mike General Counsel & Corp. Sec'y |
7,751 | $26.62 | $206,329 | 50,789 (Direct) |
View |
2023-03-30 Sale |
2023-04-03 7:01 pm |
PLIANT THERAPEUTICS INC. | PLRX | Lefebvre Eric Chief Medical Officer |
11,245 | $26.52 | $298,228 | 145,786 (Direct) |
View |
2023-03-30 Sale |
2023-04-03 6:51 pm |
PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer |
9,036 | $26.52 | $239,643 | 233,755 (Indirect Direct) |
View |
2023-03-30 Sale |
2023-04-03 6:48 pm |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
9,960 | $26.52 | $264,148 | 148,470 (Direct) |
View |
2023-03-30 Sale |
2023-04-03 6:46 pm |
PLIANT THERAPEUTICS INC. | PLRX | Coulie Bernard President and CEO |
35,339 | $26.52 | $937,222 | 684,070 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-08-03 Exercise |
2023-08-07 8:50 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer |
10,591 | $2.08 | 298,171 (Direct) |
View |
2023-08-03 Exercise |
2023-08-07 8:50 pm |
N/A 2028-03-31 |
PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer |
10,591 | $0 | 298,171 (Direct) |
View |
2023-07-14 Option Award |
2023-07-18 7:26 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Ouimette Mike General Counsel & Corp. Sec'y |
27,187 | $0 | 77,976 (Direct) |
View |
2023-07-14 Option Award |
2023-07-18 7:22 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Lefebvre Eric Chief Medical Officer |
43,750 | $0 | 189,536 (Direct) |
View |
2023-07-14 Option Award |
2023-07-18 7:19 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer |
35,156 | $0 | 268,911 (Direct) |
View |
2023-07-14 Option Award |
2023-07-18 7:17 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
38,750 | $0 | 223,770 (Direct) |
View |
2023-07-14 Option Award |
2023-07-18 7:14 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Coulie Bernard President and CEO |
137,500 | $0 | 821,570 (Direct) |
View |
2023-06-13 Exercise |
2023-06-14 6:14 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
30,750 | $2.08 | 282,067 (Direct) |
View |
2023-06-13 Exercise |
2023-06-14 6:14 pm |
N/A 2029-01-24 |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
30,750 | $0 | 282,067 (Direct) |
View |
2023-06-09 Exercise |
2023-06-12 6:19 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
5,800 | $2.08 | 282,067 (Direct) |
View |
2023-06-09 Exercise |
2023-06-12 6:19 pm |
N/A 2029-01-24 |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
5,800 | $0 | 282,067 (Direct) |
View |
2023-06-07 Option Award |
2023-06-08 5:26 pm |
N/A 2033-06-07 |
PLIANT THERAPEUTICS INC. | PLRX | Shah Smital Director |
14,000 | $0 | 14,000 (Direct) |
View |
2023-06-07 Option Award |
2023-06-08 5:24 pm |
N/A 2033-06-07 |
PLIANT THERAPEUTICS INC. | PLRX | PYOTT DAVID E I Director |
14,000 | $0 | 14,000 (Direct) |
View |
2023-06-07 Option Award |
2023-06-08 5:22 pm |
N/A 2033-06-07 |
PLIANT THERAPEUTICS INC. | PLRX | MCCOURT Thomas A Director |
14,000 | $0 | 14,000 (Direct) |
View |
2023-06-07 Option Award |
2023-06-08 5:19 pm |
N/A 2033-06-07 |
PLIANT THERAPEUTICS INC. | PLRX | Knobil Katharine Director |
14,000 | $0 | 14,000 (Direct) |
View |
2023-06-07 Option Award |
2023-06-08 5:16 pm |
N/A 2033-06-07 |
PLIANT THERAPEUTICS INC. | PLRX | Huh Hoyoung Director |
14,000 | $0 | 14,000 (Direct) |
View |
2023-06-07 Option Award |
2023-06-08 5:14 pm |
N/A 2033-06-07 |
PLIANT THERAPEUTICS INC. | PLRX | Curnutte John T Director |
14,000 | $0 | 14,000 (Direct) |
View |
2023-06-07 Option Award |
2023-06-08 5:11 pm |
N/A 2033-06-07 |
PLIANT THERAPEUTICS INC. | PLRX | CROWELL GAYLE A Director |
14,000 | $0 | 14,000 (Direct) |
View |
2023-06-07 Option Award |
2023-06-08 5:09 pm |
N/A 2033-06-07 |
PLIANT THERAPEUTICS INC. | PLRX | Cline Darren S Director |
14,000 | $0 | 14,000 (Direct) |
View |
2023-06-07 Option Award |
2023-06-08 5:06 pm |
N/A 2033-06-07 |
PLIANT THERAPEUTICS INC. | PLRX | Bruhn Suzanne Louise Director |
14,000 | $0 | 14,000 (Direct) |
View |
2023-03-29 Option Award |
2023-03-31 6:05 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Ouimette Mike General Counsel & Corp. Sec'y |
13,593 | $0 | 58,540 (Direct) |
View |
2023-03-29 Option Award |
2023-03-31 6:02 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Lefebvre Eric Chief Medical Officer |
21,874 | $0 | 157,031 (Direct) |
View |
2023-03-29 Option Award |
2023-03-31 5:59 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Hull Hans Chief Business Officer |
17,578 | $0 | 242,791 (Direct) |
View |
2023-03-29 Option Award |
2023-03-31 5:56 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Cummings Keith Lamont Chief Financial Officer |
19,375 | $0 | 158,430 (Direct) |
View |
2023-03-29 Option Award |
2023-03-31 5:54 pm |
N/A N/A |
PLIANT THERAPEUTICS INC. | PLRX | Coulie Bernard President and CEO |
68,749 | $0 | 719,409 (Direct) |
View |
2023-03-06 Option Award |
2023-03-08 4:42 pm |
N/A 2033-03-06 |
PLIANT THERAPEUTICS INC. | PLRX | MCCOURT Thomas A Director |
22,000 | $0 | 22,000 (Direct) |
View |